$CRTG
CORETEC GROUP INC.

2020 Q4 Form 10-K Financial Statement

#000143774921005962 Filed on March 12, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $248.7K $257.5K $1.487M
YoY Change -3.43% 61.72% 97.92%
% of Gross Profit
Research & Development $30.00K $20.06K $148.9K
YoY Change 49.55% -12.44% 75.01%
% of Gross Profit
Depreciation & Amortization $20.06K $20.25K $756.00
YoY Change -0.94% 0.0% 0.0%
% of Gross Profit
Operating Expenses $283.3K $277.5K $148.9K
YoY Change 2.09% 52.39% 75.01%
Operating Profit
YoY Change
Interest Expense -$307.6K -$57.30K $287.3K
YoY Change 436.86% -43.44% -27.25%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income -$590.9K -$334.8K -$1.854M
YoY Change 76.49% 40.43% 77.2%
Income Tax
% Of Pretax Income
Net Earnings -$590.9K -$334.8K -$1.854M
YoY Change 76.49% 40.43% 77.2%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.805K -$4.429K -$26.15K
COMMON SHARES
Basic Shares Outstanding 70.19M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.22K $58.15K $58.15K
YoY Change -61.79% 1353.75% 1353.75%
Cash & Equivalents $22.22K $58.15K
Short-Term Investments
Other Short-Term Assets $180.0K $88.82K $88.82K
YoY Change 102.61% 138.51% 138.51%
Inventory
Prepaid Expenses $180.0K $88.82K
Receivables
Other Receivables
Total Short-Term Assets $202.2K $147.0K $147.0K
YoY Change 37.57% 256.39% 256.38%
LONG-TERM ASSETS
Property, Plant & Equipment $126.00 $130.00
YoY Change -85.71% -85.23%
Goodwill $166.0K $166.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.95K $3.580K $3.580K
YoY Change 429.33% 54.31% 54.31%
Total Long-Term Assets $1.244M $1.309M $1.309M
YoY Change -4.96% -5.74% -5.74%
TOTAL ASSETS
Total Short-Term Assets $202.2K $147.0K $147.0K
Total Long-Term Assets $1.244M $1.309M $1.309M
Total Assets $1.446M $1.456M $1.456M
YoY Change -0.67% 1.82% 1.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $615.8K $615.8K
YoY Change -35.05% 3.01% 3.01%
Accrued Expenses $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $46.58K $39.14K $39.14K
YoY Change 19.01% -58.7% -58.7%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $442.6K $655.0K $655.0K
YoY Change -32.42% -77.33% -77.33%
LONG-TERM LIABILITIES
Long-Term Debt $266.6K $120.5K $120.5K
YoY Change 121.22%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $266.6K $120.5K $120.5K
YoY Change 121.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $442.6K $655.0K $655.0K
Total Long-Term Liabilities $266.6K $120.5K $120.5K
Total Liabilities $709.2K $775.5K $775.5K
YoY Change -8.55% -73.16% -73.16%
SHAREHOLDERS EQUITY
Retained Earnings -$7.339M -$5.494M
YoY Change 33.58% 50.95%
Common Stock $42.75K $38.70K
YoY Change 10.45% 182.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $737.0K $680.5K $680.5K
YoY Change
Total Liabilities & Shareholders Equity $1.446M $1.456M $1.456M
YoY Change -0.67% 1.82% 1.82%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$590.9K -$334.8K -$1.854M
YoY Change 76.49% 40.43% 77.2%
Depreciation, Depletion And Amortization $20.06K $20.25K $756.00
YoY Change -0.94% 0.0% 0.0%
Cash From Operating Activities -$318.2K -$383.8K -$612.5K
YoY Change -17.09% 483.49% -3.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 316.8K 433.3K 666.6K
YoY Change -26.88% 615.83% 295.54%
NET CHANGE
Cash From Operating Activities -318.2K -383.8K -612.5K
Cash From Investing Activities
Cash From Financing Activities 316.8K 433.3K 666.6K
Net Change In Cash -1.440K 49.47K 54.15K
YoY Change -102.91% -1042.29% -111.6%
FREE CASH FLOW
Cash From Operating Activities -$318.2K -$383.8K -$612.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1243972
CY2019Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1308830
CY2020 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y109D
CY2020Q4 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
CY2020 crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.052
CY2020 crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
1620000
CY2020 crtg Convertible Preferred Stock Volume Weighted Average Price Trigger
ConvertiblePreferredStockVolumeWeightedAveragePriceTrigger
15
CY2020 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
61977
CY2019 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
39806
CY2020 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
1386681
CY2019 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
806503
CY2020 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
1049826
CY2019 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
281837
CY2019Q3 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
881500
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
crtg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exchanged
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExchanged
3000000
CY2020 crtg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exchanged
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExchanged
3000000
crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
1800000
CY2020 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
1800000
CY2019 crtg Stock Issued During Period Value Interest And Accrued Interest
StockIssuedDuringPeriodValueInterestAndAccruedInterest
693924
CY2019 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
19054
CY2020 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
11470
CY2020 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
CY2020 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
11470
CY2019 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
487315
CY2020 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
360
CY2019 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
CY2020 crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
CY2019 crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
115869
CY2020Q4 crtg Working Capital Deficit
WorkingCapitalDeficit
240417
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
239267102
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Public Float
EntityPublicFloat
6217446
CY2020 dei Entity Registrant Name
EntityRegistrantName
CORETEC GROUP INC.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
396019
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
615815
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8033313
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6135885
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
281837
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1049826
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
881500
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
92496
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
60593
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
135705
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
572091
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
55839
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80229
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80229
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61270973
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35849842
CY2020Q4 us-gaap Assets
Assets
1446154
CY2019Q4 us-gaap Assets
Assets
1455926
CY2020Q4 us-gaap Assets Current
AssetsCurrent
202182
CY2019Q4 us-gaap Assets Current
AssetsCurrent
146970
CY2020Q4 us-gaap Cash
Cash
22219
CY2019Q4 us-gaap Cash
Cash
58149
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58149
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4001
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35930
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54148
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
570000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2190000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213751145
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
193521506
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213751145
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193521506
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
42750
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
38704
CY2019 us-gaap Depreciation
Depreciation
756
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1846232
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
1854385
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18946
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3575
CY2020 us-gaap Depreciation
Depreciation
126
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.009
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.026
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
112554
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
80000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1059026
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1139255
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1250
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1029136
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1418203
CY2020Q4 us-gaap Goodwill
Goodwill
166000
CY2019Q4 us-gaap Goodwill
Goodwill
166000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-208326
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
126845
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
15371
CY2019 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
91142
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
52844
CY2020 us-gaap Interest Expense
InterestExpense
665232
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
39806
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
61977
CY2019 us-gaap Interest Expense
InterestExpense
287307
CY2020 us-gaap Interest Paid Net
InterestPaidNet
84366
CY2019 us-gaap Interest Paid Net
InterestPaidNet
50237
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
92496
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
765631
CY2020Q4 us-gaap Liabilities
Liabilities
709197
CY2019Q4 us-gaap Liabilities
Liabilities
775461
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1446154
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1455926
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
442599
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
654953
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1316972
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
666607
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1352902
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-612459
us-gaap Net Income Loss
NetIncomeLoss
-7339175
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1844982
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1854385
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
46580
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
39138
CY2019Q1 us-gaap Notes Payable Current
NotesPayableCurrent
39138
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
266598
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
120508
CY2019Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
120508
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
25592
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
23760
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1250
CY2019 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
225664
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
22767
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179963
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
88821
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><div style="display: inline; font-style: italic;">Reclassification</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Certain amounts in the prior period year balance sheet and statement of operations have been reclassified to conform to the presentation of the current year. These reclassifications were immaterial and had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the previously reported net loss.</div></div></div></div></div></div></div></div></div></div>
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
69709
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
117129
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
151864
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148875
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5494193
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21500000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1500000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.057
CY2019Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.041
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.057
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
19462174
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
20212174
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y251D
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
550000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2017434
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1459299
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</div></div></div></div></div></div></div></div></div></div>
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
202680171
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70919722

Files In Submission

Name View Source Status
0001437749-21-005962-index-headers.html Edgar Link pending
0001437749-21-005962-index.html Edgar Link pending
0001437749-21-005962.txt Edgar Link pending
0001437749-21-005962-xbrl.zip Edgar Link pending
crtg-20201231.xml Edgar Link completed
crtg-20201231.xsd Edgar Link pending
crtg-20201231_cal.xml Edgar Link unprocessable
crtg-20201231_def.xml Edgar Link unprocessable
crtg-20201231_lab.xml Edgar Link unprocessable
crtg-20201231_pre.xml Edgar Link unprocessable
crtg20201231_10k.htm Edgar Link pending
ex_232667.htm Edgar Link pending
ex_232668.htm Edgar Link pending
ex_232669.htm Edgar Link pending
ex_232670.htm Edgar Link pending
ex_233010.htm Edgar Link pending
ex_233011.htm Edgar Link pending
ex_233444.htm Edgar Link pending
ex_233682.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending